Navigation Links
Data study suggests cortisol could alleviate for chronic fatigue syndrome and fibromyalgia
Date:3/19/2008

LOS ANGELES March 19, 2008 Chronic fatigue syndrome (CFS) and fibromyalgia (FM) are two serious and debilitating diseases with no confirmed cause and limited treatment options. However, results of a new comprehensive literature study propose a simplified treatment process that could help alleviate symptoms for patients suffering from these diseases.

Kent Holtorf, M.D., medical director of the Holtorf Medical Group Center for Endocrine, Neurological and Infection related illness Torrance, Calif., is advising a simplified treatment process that may help alleviate CFS and FM symptoms. From an extensive review of more than 50 published studies that assessed adrenal function in CFS and FM patients, Dr. Holtorf found that that the majority of CFS and FM patients displayed abnormal adrenal function due to hypothalamic-pituitary dysfunction. The comprehensive review also showed that the majority of patients could be treated for this adrenal dysfunction. Dr. Holtorfs analysis, recently published in the Journal of Chronic Fatigue Syndrome, demonstrated that patients that were given cortisol as part of a multi-system treatment experienced significant improvement in their symptoms.

My review of existing studies suggests that a treatment protocol of early administration of cortisol may help improve and reduce the symptoms of chronic fatigue syndrome and fibromyalgia, said Dr. Holtorf. This research provides a new understanding that treating the known causes of illness in CFS and FM can improve the symptoms and quality-of-life of patients who suffer from these conditions.

CFS and FM primarily affect women in their 30s and 40s. According to the Centers for Disease Control and Prevention (CDC) more than one million Americans suffer from CFS while it is estimate that FM affects about 2 percent of the U.S. population. Unfortunately, both of these diseases are poorly understood by many physicians and there is no generally accepted test to accurately detect them. In addition, many CFS and FM patients express frustration because there is no clear treatment path for their conditions.

Dr. Holtorfs research was further confirmed in an observational study following the conditions of 500 patients from his clinic, where of the patients given cortisol as part of their treatment protocol:

  • 94 percent showed improvement by the fourth visit;
  • 75 percent noted significant improvement;
  • 62 percent reported substantial improvement; and
  • Energy levels and a general sense of well-being for patients doubled by the fourth visit.

The effectiveness of this multi-system treatment was further confirmed through the analysis of the cumulative findings of over 40 independent physicians and over 5,000 patients.

As shown in the Journal of Chronic Fatigue Syndrome study, cortisol doses of 5-to-15mg a day have been shown to be safe, with little or no associated risk while having the potential for significant benefit for CFS and FM patients.

Cortisol treatment carries significantly less risk and a greater potential for benefit than treatments considered to be the standard of care for both conditions, Dr. Holtorf explains.


'/>"/>

Contact: Julian Teixeira
julian.teixeira@zenogroup.com
202-965-7808
Edelman Public Relations
Source:Eurekalert

Related medicine news :

1. Evanston-Northwestern Study Proves Effectiveness of MRSA Screening to Reduce Hospital Infections
2. MTM Study Reports Improved Quality and Economic Outcomes Using Medication Management Systems Assurance Pharmaceutical Care System(TM)
3. New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies
4. Neighborhoods play key role in how much people exercise, study says
5. Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma
6. Cancer detected earlier, faster, with new medical imaging, Stanford study finds
7. Study Finds Potential Cause of Age-Related Macular Degeneration
8. New Study: Pycnogenol(R) Improves Memory in Elderly
9. Researchers study new drug and indications for heated chemotherapy treatment
10. Scripps research team wins $4M grant to study effects of chronic marijuana use
11. Meditation impacts blood pressure, study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... , ... With ProGlass Prism users now have the ability to simulate prism ... position, rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass position offset, anchor ... Prism users are given the tools and effects to generate a fractal prismatic ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that he ... of the Management Committee when IFN was originally formed in 2002 where he was ... development of the business plan. He became the first paid employee of IFN ...
(Date:2/24/2017)... ... 24, 2017 , ... Castle Farms, the celebrated Northern ... with the winning couple announced on Feb. 14, 2017, on Facebook. The free ... vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring and ...
(Date:2/23/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Beach to host its Swirl: Miami Wine Tasting Event on March 28, 2017. ...
(Date:2/23/2017)... ... 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, dentist in ... the month of February, patients who visit Hamlin Dental Group will receive a ticket ... two at the Cheesecake Factory. , Tickets are available for routine dental visits ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Research and Markets has announced the addition ... 2016" report to their offering. ... The latest research Urinary Incontinence Drugs Price ... in the global Urinary Incontinence market. The research answers the ... drugs marketed for Urinary Incontinence and their clinical attributes? How are ...
(Date:2/23/2017)... Research and Markets has announced the addition ... - 2016" report to their offering. ... The latest research Autism Spectrum Disorder ... and benchmarks in the global Autism Spectrum Disorder market. The ... are the key drugs marketed for Autism Spectrum Disorder and their ...
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG ... für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des ... ultraviolette Strahlung im Bereich zwischen 200 und 280 nm und ... von Bakterien, indem es ihre DNA zerstört. Das Produkt ... ...
Breaking Medicine Technology: